These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31130327)

  • 1. Multiple pathways for natural product treatment of Parkinson's disease: A mini review.
    Li J; Long X; Hu J; Bi J; Zhou T; Guo X; Han C; Huang J; Wang T; Xiong N; Lin Z
    Phytomedicine; 2019 Jul; 60():152954. PubMed ID: 31130327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
    Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
    J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A natural product from Cannabis sativa subsp. sativa inhibits homeodomain-interacting protein kinase 2 (HIPK2), attenuating MPP
    Wang G; Zhu L; Zhao Y; Gao S; Sun D; Yuan J; Huang Y; Zhang X; Yao X
    Bioorg Chem; 2017 Jun; 72():64-73. PubMed ID: 28366826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.
    Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G
    Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNB-001, a novel pyrazole derivative mitigates motor impairments associated with neurodegeneration via suppression of neuroinflammatory and apoptotic response in experimental Parkinson's disease mice.
    Jayaraj RL; Elangovan N; Dhanalakshmi C; Manivasagam T; Essa MM
    Chem Biol Interact; 2014 Sep; 220():149-57. PubMed ID: 24995576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular phenotypes as inflammatory mediators in Parkinson's disease: Interventional targets and role of natural products.
    Jiang X; Ganesan P; Rengarajan T; Choi DK; Arulselvan P
    Biomed Pharmacother; 2018 Oct; 106():1052-1062. PubMed ID: 30119171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway.
    Shao S; Wang GL; Raymond C; Deng XH; Zhu XL; Wang D; Hong LP
    Mol Med Rep; 2017 Aug; 16(2):1269-1277. PubMed ID: 28627590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds.
    Zhang H; Bai L; He J; Zhong L; Duan X; Ouyang L; Zhu Y; Wang T; Zhang Y; Shi J
    Eur J Med Chem; 2017 Dec; 141():257-272. PubMed ID: 29031072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?
    Ziv I; Offen D; Barzilai A; Haviv R; Stein R; Zilkha-Falb R; Shirvan A; Melamed E
    J Neural Transm Suppl; 1997; 49():195-202. PubMed ID: 9266428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway.
    Liu Y; Geng L; Zhang J; Wang J; Zhang Q; Duan D; Zhang Q
    Mar Drugs; 2018 Mar; 16(3):. PubMed ID: 29509717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease.
    Dong Y; Han LL; Xu ZX
    Mol Med; 2018 Nov; 24(1):61. PubMed ID: 30486773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory and anti-apoptotic effects of (RS)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease.
    Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
    Bioorg Med Chem; 2013 Sep; 21(17):5532-47. PubMed ID: 23810671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurr1 overexpression exerts neuroprotective and anti-inflammatory roles via down-regulating CCL2 expression in both in vivo and in vitro Parkinson's disease models.
    Liu W; Gao Y; Chang N
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1312-1319. PubMed ID: 27940361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory effects of costunolide on dopamine metabolism-associated genes inhibit dopamine-induced apoptosis in human dopaminergic SH-SY5Y cells.
    Ham A; Lee SJ; Shin J; Kim KH; Mar W
    Neurosci Lett; 2012 Jan; 507(2):101-5. PubMed ID: 22040670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.